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Abstract: The reaction between 1,4-di-Grignard reagents and phosphonous(III) dichlorides is a classical method for 
the direct synthesis of phospholanes. Reported here is an extension of this approach to the preparation of value-added, 
annulated phospholane oxides, achieved through the combination of carbocyclic-fused di-Grignard reagents and readily 
available phosphonic(V) dichlorides. The procedure is amenable to (benz)annulation at both the 2,3- and 3,4-positions 
of the phospholane ring, and a variety of aliphatic, cyclic and aryl P-electrophiles are tolerated in reasonable to 
excellent yields. 
 
The phospholane ring system is a ubiquitous heterocycle in organic synthesis, upon which a plethora of P-ligands1 and 
nucleophilic organocatalysts1c,2 are based. In particular, the privileged BPE and DuPhos families,3 bearing 2,5-
disubstituted phospholanes (1 and 2, Figure 1), have seen extensive application in metal-mediated4 and metal-free 
asymmetric catalysis.2 The P-stereogenic TangPhos/DuanPhos/ZhangPhos series (3−5),5 based on 1,1'-di-tert-butyl-
2,2'-biphospholane and its 3,4-annulated derivatives, is another notable contribution, encompassing some of the most 
effective ligands ever reported for asymmetric hydrogenation.6 
 
 
Figure 1. Exemplary P-ligands and organocatalysts containing the phospholane moiety. 
 
Recently, phospholane oxides and their bi- and tricyclic derivatives (fused and bridged), have emerged as effective pre-
catalysts for an expanding new area of organocatalysis involving the P(III):↔P(V)=O redox pair (e.g., 7−9, Figure 1).7 
The virtue of these heterocycles to participate in such a catalysis mode stems from their increased rate of reduction 
compared to their larger ring-homologues and acyclic counterparts.7,8 Current areas of development include catalytic 
Wittig,9 aza-Wittig10 and Appel reactions8,11 and very recently, deoxygenative condensations.12 
The most common approach to assemble the phospholane system involves the combination of lithiated primary 
phosphines or phosphine-boranes with 1,4-bis-electrophiles, enabling consecutive inter- and intramolecular P−C bond 
formations in a single pot. This strategy has furnished a range of valuable phospholanes,1c including bicyclic 
adducts,5a,b,13 and can be extended to secondary alkyl electrophiles in a stereospecific manner.3a,14 Despite these 
favourable aspects, the requirement for the handling and use of pungent, odorous and potentially pyrophoric primary 
phosphines, remains a significant drawback. Furthermore, this approach is not readily amenable to benzannulation at 
the phospholane 2,3-position,15 an emerging structural feature of useful ligands and organocatalysts (e.g., 6 and 9, 
Figure 1).8,12a,15,16 
In our search for an alternate phospholane syntheses that would avoid the use of primary phosphines, while still 
circumventing acyclic organophosphorus intermediates17 and backbone redox manipulations,18 common to most 
available routes, we turned our attention to the classical umpolung approach, in which a 1,4-diorganometallic reagent is 
reacted with a P-electrophile. This method was first introduced by Grüttner for the preparation of phenyl phospholane 
from di-Grignard reagent 10 (Scheme 1a),19 and has since been applied to a variety of analogues 11 using 
phosphonous(III) dichlorides5c,14b,20 or other trivalent P reagents,21 typically by trapping the products as their stable 
borane or sulfide adducts. 
Scheme 1. Proposed Synthesis of Annulated Phospholanes 
 
Encouraged by these findings, and considering the fact that extensions of this umpolung synthetic strategy to mono-
annulated phospholanes (i.e., 13, Scheme 1b) have been limited,22 we were inspired to investigate in more detail the 
application of carbocyclic-fused di-Grignard reagents 12 in this setting.23 From an additional standpoint, we were 
drawn to the potential of using higher oxidation level phosphonic(V) dichlorides as electrophiles, which have 
surprisingly remained an essentially unexplored class of reagents for phospholane synthesis,24 or homologues thereof. 
Notably, the latter modification would open up a direct entry to phospholane oxides (Scheme 1a). Several practical 
 
benefits could also be envisioned including the stability of P(V) reagents to oxygen, the wide range of commercially 
available phosphonic dichlorides and their phosphonic acid precursors,25 and the avoidance of an oxidative work-up 
otherwise required to isolate the desired P-oxide.  
Our initial synthetic investigations were based on phenyl phospholane oxide (19 in Table 1) as a model system through 
the reaction of di-Grignard reagent 10 and commercially available POPhCl2. A previous study of a related reaction 
between phosphate ester dichlorides (PO(OR)Cl2) and 10 highlighted the difficulty in achieving cyclization at the P(V) 
oxidation state due to undesired oligomerizaton.26 After experiencing similarly low yields of 19 (25−35%) under 
standard conditions (0 °C−rt),19,20,26 we progressed to examine the effect of lower temperatures which, surprisingly, to 
our knowledge, had never been investigated for the related esters.26 In the event, by mixing the reactants at −78 °C (1:1 
in THF, 0.1 M), a significant suppression of oligomerization was realized to give 19 in a highly respectable 75% yield 
(Table 1, entry 1), representing a notable improvement relative to previous syntheses of phenyl phospholane from 
diorganometallic and P(III) reagents (optimum lit. yields given in Table 1, entry 1).19,20a,b,27 
Table 1. Di-Grignard Scopea 
 
entry di-Grignard reagentb product yield (%)c lit. yield (%)d
1  10 
 
19 75 
 
46e,20b, 56f,27 
(one step) 
2 
 
14 
 
(±)-20 87 
 
8028a 
(three steps) 
3 
 
15 
 
(±)-21 57 
 
3630  
(two steps) 
4 
 
(±)-16 
 
(±)-22 57 - 
5 
 
meso-17
meso-(sP)-23
meso-(rP)-23
43g 
16g 
- 
6  18 
 
24 36 
 
7532 
(three steps) 
 
a Reactions performed with 0.30−0.58 mmol of POPhCl2 at 0.05−0.10 M. 
b Di-Grignard reagents were prepared in THF with 2.1 
equiv of acid-washed Mg flakes and titrated with 1,10-phenanthroline/2-butanol prior to use. c Isolated yield after flash 
chromatography. d Highest yield reported among all previous methods. e Yield of the corresponding BH3 adduct obtained from 10 
and PPhCl2. 
f Yield of deoxo-19 obtained from Li(CH2)4Li and PPh(OMe)2. 
g Diastereomers separated by flash chromatography. 
 
With a practical and efficient procedure established, we submitted a series of carbocyclic-fused 1,4-di-Grignard 
reagents (14−17) to the reaction with POPhCl2 (Table 1, entries 2−5). The known P-stereogenic benzo- and 
naphthophospholanes (±)-20 and (±)-21 were obtained in 87% and 57% yields, respectively, comparing favourably 
with previous multistep routes to these compounds (entries 2 and 3).28−30 Utilizing racemic di-Grignard reagent 16, the 
novel bicyclic phospholane oxide (±)-22 was isolated in a moderate 57% yield (entry 4). The rigid trans-cyclohexane-
annulated chiral backbone of 22 represents an unsaturated monomeric analogue to the skeleton of ZhangPhos (5, 
Figure 1), which has been previously obtained by the inverse addition of a nucleophilic primary phosphine and the 
corresponding 1,4-bis-electrophile.5a Translation to the homochiral variants of 22 can be readily envisioned, based on 
the commercial availability of the requisite enantiopure precursors.31  
The corresponding cis-di-Grignard reagent 17 reacted similarly with PPhOCl2 to give chromatographically separable 
meso-diastereomers (sP)-23 and (rP)-23 in a 59% combined yield (Table 1, entry 5), which bear additional P-
stereocenters on the molecular symmetry plane. The major isomer was determined by X-ray crystallography to have 
the (sP)-configuration at the phosphorus atom, in which the phenyl group lies in an exo relationship to the annulated 
cyclohexene ring (Figure 2). We also established that the method can be extended to six-membered homologues using 
exemplary di-Grignard reagent 18 (entry 6), however reduced yields should be expected due to a greater degree of 
oligomerization.33 
 
Figure 2. X-ray crystal structure of meso-(sP)-23 with an ellipsoid contour % probability level of 30%. 
We next turned our attention to the scope of the process with respect to the phosphonic dichloride, targeting a series of 
novel naphthophospholane derivatives (Table 2). The requisite electrophiles were obtained commercially or by a 
simple chlorination procedure using oxalyl chloride,25,34 allowing access to a variety of products (25−31) in moderate 
to excellent yields (49−88%). Functionalized 2-methoxy- and 3-bromophenylphosphonic dichlorides provided (±)-25 
and (±)-26 in yields comparable to their unsubstituted analogue (±)-21 (Table 1, entry 3). The 1-naphthyl substrate 
performed particularly well, giving (±)-27 in 79% yield, the structure of which was confirmed by X-Ray 
crystallography (Table 2, insert). Importantly, sterically encumbered aliphatic P-substituents commonly exploited in 
 
phosphine ligands were well tolerated including tert-butyl and cyclohexyl moieties. A phosphoramide dichloride 
(PO(NMe2)Cl2) was also accommodated, affording phosphinamide derivative (±)-31 in high yield (88%). 
Table 2. Electrophile Scopea 
 
a Reactions performed with 0.32−0.50 mmol of PORCl2 at 0.08−0.10 M. Yields are of isolated product after flash chromatography. 
b Chlorination conditions: (COCl)2, DMF (cat.), CH2Cl2, rt−40 °C, 1 h.
25 c PORCl2 was obtained commercially. The ellipsoid 
contour % probability level of the X-ray structure of 27 is 30%. 
 
In addition to having showcased the ability to tune the electronic and steric properties of the naphthophospholane 
scaffold via this methodology, it is noteworthy that versatile functional handles for further manipulation have been 
introduced (e.g., allyl, bromo and methoxy). Based on more specific precedents, the methoxy group could offer a 
potential means of resolving (±)-25 via the diastereomeric menthyl carbonates,16 while the phosphinamide moiety in 31 
should permit a facile entry into the corresponding phosphonic acid35 which could, for instance, be reduced to the 
corresponding secondary phosphine oxide,35b,36 the secondary phosphine,3a,36 or diastereomerically resolved.35b  
In summary, we have established that annulated phospholane oxides can be obtained in a practical and efficient manner 
through the combination of phosphonic dichlorides and di-Grignard reagents. The significance of this method has been 
demonstrated by the synthesis of representative known compounds in superior yields than obtained with previous 
methods, its application to backbone-chiral and P-stereogenic phospholanes, and the straightforward electronic and 
steric modulation of a representative heterocycle through P-substituent variations. The latter is of particular importance 
in the context of analogue throughput in catalyst screening studies, which, as pointed out, could involve applications of 
the phospholane oxides as new organocatalysts or alternatively, as templates for P-ligand design, based on their well 
 
precedented ability to undergo diastereoselective α-C(sp3)−H functionalization,18a,37 including oxidative dimerization to 
1,2-bisphosphines.5b,16 
Experimental Section 
General Methods and Materials. All reactions were carried out in standard laboratory glassware with magnetic 
stirring. Thin layer chromatography (TLC) was performed on aluminum-backed 0.20 mm silica gel plates. 
Visualization was accomplished with UV light. Flash chromatography was performed under positive air pressure using 
Silica Gel 60 of 230−400 mesh (40−63 m). Melting points (mp) are uncorrected. Proton and carbon magnetic 
resonance spectra (1H NMR and 13C NMR) were recorded on a 300 MHz or 500 MHz spectrometer, as specified. 
Spectra were aquired in CDCl3 and are reported relative to tetramethylsilane (
1H:  = 0.00 ppm) and solvent resonance 
(13C:  = 77.0 ppm). 1H NMR data are reported as follows: chemical shift, multiplicity (abbreviations: d = doublet, dd 
= doublet of doublets, ddd = doublet of doublets of doublets, t = triplet, td = triplet of doublets, m = multiplet), 
coupling constant (Hz) and integration. Coupling constants listed in the 13C NMR spectral data refer to coupling 
between carbon and phosphorus nuclei. High resolution mass spectrometry (HRMS) was performed on a QTOF ESI 
spectrometer. 
Anhydrous tetrahydrofuran was obtained commercially. Di-Grignard reagents were prepared from Mg flakes that were 
freshly washed with 1 M HCl, followed sequentially by water, EtOH, THF and Et2O before being dried for 20 min 
under high vacuum. 1-Bromo-2-(2-chloroethyl)benzene,38 1-bromo-2-(2-chloroethyl)naphthalene,31 (±)-trans-4,5-
bis(bromomethyl)cyclohex-1-ene31 and cis-4,5-bis(bromomethyl)cyclohex-1-ene39 were prepared according to 
literature procedures. Phenylphosphonic dichloride (POPhCl2), tert-butylphosphonic dichloride (PO(t-Bu)Cl2) and 
N,N-dimethylphosphoramide dichloride (PO(NMe2)Cl2) were obtained commercially. The remaining phosphonic 
dichlorides utilized in Table 2 were prepared from their corresponding known phosphonic acids via chlorination with 
oxalyl chloride.25,34 All other reagents and solvents were obtained reagent grade from commercial sources and used as 
received. 
General Procedure A for the Preparation of Di-Grignard Reagents. A dry round-bottom flask was charged with 
the appropriate neat di-halo compound (0.24−0.58 mmol, 1.0 equiv) and Mg (2.1 equiv).40 The flask was evacuated and 
refilled with N2 (single cycle), then THF was added (0.50 M in di-halo compound) and the suspension was stirred 
rapidly for 2 h at a temperature dependent on the substrate. Aliphatic di-Grignard reagents (10, (±)-16, meso-17 and 18) 
were prepared at rt, while mixed aliphatic/aromatic substrates (14 and 15) were prepared by gradually heating from rt 
to 65 °C over 30 min, maintaining this temperature for 1 h, then returning to rt over 30 min (for these reactions, the 
flask was equipped with a condenser). In each case, titration of the resultant supernatant was carried out with a 1.00 M 
solution of 2-butanol in toluene using 1,10-phenanthroline as indicator41 to determine the total concentration of 
organomagnesium species, which was halved to obtain the di-Grignard reagent concentration quoted in the 
experimental descriptions below.  
General Procedure B for the Synthesis of Cyclic Phosphine Oxides from Di-Grignard Reagents. To a solution of 
a phosphonic dichloride (0.30−0.58 mmol) in the specified volume of THF at −78 °C (liquid N2/EtOAc slush bath) 
under N2 was added dropwise over 2 min a solution of a freshly titrated di-Grignard reagent (1.0 equiv) in THF. The 
 
resulting solution (generally 0.10 M in both reactants) was allowed to warm to rt with stirring over 20 h. The reaction 
was quenched with water (5 mL), then saturated NH4Cl (5 mL) was added, followed by EtOAc (20 mL). The organic 
layer was separated and the aqueous layer further extracted with EtOAc (2×20 mL). The combined organic extracts 
were dried (MgSO4) and concentrated under reduced pressure. Flash chromatography with the specified eluent 
provided the desired cyclic phosphine oxide. 
 
1-Phenylphospholane-1-oxide (19). This was prepared according to General Procedure B using a solution of POPhCl2 
(97.5 mg, 0.50 mmol) in THF (3.31 mL) and a solution of di-Grignard reagent 10 (0.295 M in THF, 1.69 mL, 0.50 
mmol). Flash chromatography (100% EtOAc to 2% NEt3/EtOAc) gave the known phospholane 19 (67.6 mg, 75%) as a 
yellow oil. NMR data was in good agreement with that previously reported.8 TLC (2% NEt3/EtOAc) RF = 0.20; 
1H 
NMR (500 MHz, CDCl3) δ 7.74 (dd, J = 11.4, 7.3 Hz, 2H), 7.56 – 7.46 (m, 3H), 2.27 – 1.88 (m, 8H); 
13C NMR (125 
MHz, CDCl3) δ 133.9 (d, J = 90.1 Hz), 131.4 (d, J = 2.9 Hz), 129.6 (d, J = 9.6 Hz), 128.4 (d, J = 11.6 Hz), 29.4 (d, J = 
67.6 Hz), 25.0 (d, J = 8.1 Hz). 
 
(racemic)-2,3-Dihydro-1-phenyl-1H-phosphindole-1-oxide (20). This was prepared according to General Procedure B 
using a solution of POPhCl2 (97.5 mg, 0.50 mmol) in THF (3.61 mL) and a solution of di-Grignard reagent 14 (0.36 M 
in THF, 1.39 mL, 0.50 mmol). Flash chromatography (100% EtOAc to 2% NEt3/EtOAc) gave the known 
benzophospholane 20 (99.8 mg, 87%) as a white solid. NMR data was in good agreement with that previously 
reported.28a mp 86−88 °C; Lit.28c mp 97−101 °C; TLC (2% NEt3/EtOAc) RF = 0.29; 
1H NMR (500 MHz, CDCl3) δ 7.66 
(t, J = 8.2 Hz, 1H), 7.62 – 7.48 (m, 4H), 7.47 – 7.34 (m, 4H), 3.49 – 3.37 (m, 1H), 3.25 – 3.14 (m, 1H), 2.54 – 2.37 (m, 
2H); 13C NMR (125 MHz, CDCl3) δ 147.3 (d, J = 30.7 Hz), 133.1 (d, J = 97.7 Hz), 132.5 (d, J = 103.1 Hz), 132.4 (d, J 
= 2.5 Hz), 131.5 (d, J = 2.9 Hz), 130.2 (d, J = 10.5 Hz), 128.6 (d, J = 9.3 Hz), 128.3 (d, J = 12.0 Hz), 127.5 (d, J = 10.4 
Hz), 126.1 (d, J = 11.4 Hz), 27.9 (d, J = 3.9 Hz), 27.8 (d, J = 71.0 Hz); IR (neat) v 3442, 1593, 1434, 1195, 1136, 1115, 
777, 765, 742 cm-1; HRMS (ESI) calcd for C14H14OP 229.0782 [M+H]
+, found 229.0790. 
 
(racemic)-1-Phenyl-2,3-dihydro-1H-benzo[g]phosphindole-1-oxide (21). This was prepared according to General 
Procedure B using a solution of POPhCl2 (113.0 mg, 0.58 mmol) in THF (3.80 mL) and a solution of di-Grignard 
reagent 15 (0.29 M in THF, 2.00 mL, 0.58 mmol). Flash chromatography (100% EtOAc to 2% NEt3/EtOAc) gave the 
known compound 21 (91.4 mg, 57%) as a white solid. Previously, no 1H NMR data and only partial 13C NMR data has 
been reported for 21. Our 13C NMR data was in good agreement with the available information.30 mp 177−178 °C; 
Lit.30 mp 200−202 °C; TLC (2% NEt3/EtOAc) RF = 0.37; 
1H NMR (300 MHz, CDCl3) δ 8.13 – 8.05 (m, 1H), 7.95 (d, J 
= 8.4 Hz, 1H), 7.86 – 7.78 (m, 1H), 7.63 (dd, J = 12.3, 7.3 Hz, 2H), 7.46 – 7.31 (m, 6H), 3.57 – 3.38 (m, 1H), 3.37 – 
3.20 (m, 1H), 2.67 – 2.38 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 147.9 (d, J = 31.1 Hz), 133.8 (d, J = 96.7 Hz), 133.7 
(d, J = 2.7 Hz), 132.5 (d, J = 8.0 Hz), 131.7 (d, J = 9.1 Hz), 131.5 (d, J = 3.0 Hz), 130.1 (d, J = 10.4 Hz), 128.4 (d, J = 
12.0 Hz), 128.2 (d, J = 1.6 Hz), 128.0 (d, J = 101.5 Hz), 127.6, 126.1, 125.1 (d, J = 4.8 Hz), 123.8 (d, J = 12.7 Hz), 
28.6 (d, J = 4.6 Hz), 27.9 (d, J = 71.4 Hz); IR (neat) v 2360, 1201, 1186, 1111, 818, 784, 740, 691 cm-1; HRMS (ESI) 
calcd for C18H16OP 279.0939 [M+H]
+, found 279.0931. 
 
 
(racemic)-Trans-2-phenyl-2,3,3a,4,7,7a-hexahydro-1H-isophosphindole 2-oxide (22). This was prepared according to 
General Procedure B using a solution of POPhCl2 (97.5 mg, 0.50 mmol) in THF (3.20 mL) and a solution of di-
Grignard reagent 16 (0.13 M in THF, 3.85 mL, 0.50 mmol). Flash chromatography (100% EtOAc to 2% NEt3/EtOAc) 
gave 22 (66.4 mg, 57%) as a white solid. mp 88−92 °C; TLC (2% NEt3/EtOAc) RF = 0.38; 
1H NMR (500 MHz, 
CDCl3) δ 7.81 – 7.71 (m, 2H), 7.59 – 7.45 (m, 3H), 5.72 (s, 2H), 2.56 – 2.35 (m, 4H), 2.30 – 2.19 (m, 1H), 2.09 – 1.98 
(m, 1H), 1.98 – 1.77 (m, 3H), 1.62 (ddd, J = 15.0, 12.5, 7.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 134.4 (d, J = 90.1 
Hz), 131.6 (d, J = 2.9 Hz), 129.8 (d, J = 9.9 Hz), 128.6 (d, J = 11.6 Hz), 126.2 (d, J = 1.9 Hz), 126.1 (d, J = 1.9 Hz), 
40.4 (d, J = 8.2 Hz), 38.9 (d, J = 7.7 Hz), 37.6 (d, J = 66.4 Hz), 36.9 (d, J = 67.6 Hz), 33.2 (d, J = 9.3 Hz), 33.0 (d, J = 
9.8 Hz); IR (neat) v 3408, 2887, 1437, 1223, 1187, 927, 852, 786, 726, 692, 655 cm-1; HRMS (ESI) calcd for C14H18OP 
233.1095 [M+H]+, found 233.1087. 
 
(meso)-(2s,3aR,7aS)-2-Phenyl-2,3,3a,4,7,7a-hexahydro-1H-isophosphindole 2-oxide ((sP)-23) and (meso)-
(2r,3aR,7aS)-2-phenyl-2,3,3a,4,7,7a-hexahydro-1H-isophosphindole 2-oxide ((rP)-23). The title compounds were 
prepared according to General Procedure B using a solution of POPhCl2 (58.0 mg, 0.30 mmol) in THF (3.00 mL) and a 
solution of di-Grignard reagent 17 (0.06 M in THF, 4.00 mL, 0.24 mmol). Flash chromatography (100% EtOAc to 5% 
NEt3/EtOAc) gave (sP)-23 (24.0 mg, 43% based on 17) as a white solid. mp 76−79 °C; TLC (5% NEt3/EtOAc) RF = 
0.55; 1H NMR (500 MHz, CDCl3) δ 7.81 – 7.74 (m, 2H), 7.55 – 7.46 (m, 3H), 5.69 (s, 2H), 2.50 – 2.32 (m, 4H), 2.31 – 
2.20 (m, 2H), 2.17 – 2.09 (m, 2H), 2.09 – 1.99 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 134.9 (d, J = 89.6 Hz), 131.2 
(d, J = 2.9 Hz), 129.5 (d, J = 9.6 Hz), 128.3 (d, J = 11.5 Hz), 123.9, 35.1 (d, J = 7.3 Hz), 34.9 (d, J = 66.4 Hz), 27.3 (d, 
J = 7.7 Hz); IR (neat) v 3400, 2904, 1653, 1436, 1407, 1180, 911, 845, 792, 744, 717, 696, 661 cm-1; HRMS (ESI) 
calcd for C14H18OP 233.1095 [M+H]
+, found 233.1085. Further elution (10% NEt3/EtOAc) gave (rP)-23 (9.0 mg, 16% 
based on 17) as an amorphous solid. TLC (5% NEt3/EtOAc) RF = 0.18; 
1H NMR (500 MHz, CDCl3) δ 7.83 – 7.75 (m, 
2H), 7.57 – 7.47 (m, 3H), 5.64 (s, 2H), 2.78 – 2.66 (m, 2H), 2.37 – 2.27 (m, 2H), 2.24 – 2.12 (m, 2H), 2.11 – 2.02 (m, 
2H), 1.94 – 1.85 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 134.6 (d, J = 90.0 Hz), 131.6 (d, J = 2.8 Hz), 130.0 (d, J = 
9.7 Hz), 128.7 (d, J = 11.8 Hz), 124.4, 34.2 (d, J = 67.0 Hz), 34.1 (d, J = 7.2 Hz), 27.5 (d, J = 7.9 Hz); IR (neat) v 
3407, 2910, 1647, 1436, 1405, 1178, 934, 846, 797, 737, 728, 694, 661 cm-1; HRMS (ESI) calcd for C14H18OP 
233.1095 [M+H]+, found 233.1095. 
 
1-Phenylphosphinane oxide (24). This was prepared according to General Procedure B using a solution of POPhCl2 
(97.5 mg, 0.50 mmol) in THF (8.68 mL) and a solution of di-Grignard reagent 18 (0.38 M in THF, 1.32 mL, 0.50 
mmol). Flash chromatography (100% EtOAc to 10% NEt3/EtOAc) gave 24 (34.6 mg, 36%) as a white solid. NMR data 
was in good agreement with that previously reported.42 mp 114−117 °C; Lit.17a mp 125−127 °C; TLC (2% 
NEt3/EtOAc) RF = 0.15; 
1H NMR (300 MHz, CDCl3) δ 7.82 – 7.70 (m, 2H), 7.57 – 7.43 (m, 3H), 2.25 – 1.70 (m, 9H), 
1.59 – 1.41 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 133.2 (d, J = 94.4 Hz), 131.6 (d, J = 2.5 Hz), 129.9 (d, J = 9.2 Hz), 
 
128.6 (d, J = 11.5 Hz), 28.2 (d, J = 65.2 Hz), 26.6 (d, J = 6.8 Hz), 22.0 (d, J = 5.6 Hz); HRMS (ESI) calcd for 
C11H16OP 195.0939 [M+H]
+, found 195.0946. 
 
(racemic)-1-(2-Methoxyphenyl)-2,3-dihydro-1H-benzo[g]phosphindole-1-oxide (25). This was prepared according to 
General Procedure B using a solution of PO(2-OMePh)Cl2 (71.9 mg, 0.32 mmol) in THF (2.13 mL) and a solution of 
di-Grignard reagent 15 (0.30 M in THF, 1.07 mL, 0.32 mmol). Flash chromatography (100% EtOAc to 2% 
NEt3/EtOAc) gave 25 (51.2 mg, 52%) as an off-white solid. mp 168−169 °C; TLC (2% NEt3/EtOAc) RF = 0.27; 
1H 
NMR (500 MHz, CDCl3) δ 8.16 (dd, J = 13.2, 7.7 Hz, 1H), 8.10 (dd, J = 6.2, 3.4 Hz, 1H), 7.92 (d, J = 8.4 Hz, 1H), 
7.85 – 7.79 (m, 1H), 7.47 – 7.37 (m, 4H), 7.12 (t, J = 7.5 Hz, 1H), 6.75 (dd, J = 8.3, 5.5 Hz, 1H), 3.55 – 3.43 (m, 4H), 
3.39 – 3.29 (m, 1H), 2.74 – 2.64 (m, 1H), 2.50 – 2.37 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 160.4 (d, J = 4.5 Hz), 
148.0 (d, J = 33.5 Hz), 134.1 (d, J = 6.2 Hz), 133.7 (d, J = 2.0 Hz), 133.1 (d, J = 2.7 Hz), 132.5 (d, J = 8.1 Hz), 132.0 
(d, J = 9.1 Hz), 128.7 (d, J = 104.4 Hz), 128.2 (d, J = 1.4 Hz), 127.5, 125.9, 125.3 (d, J = 4.7 Hz), 123.9 (d, J = 13.3 
Hz), 121.4 (d, J = 95.6 Hz), 120.9 (d, J = 11.1 Hz), 110.9 (d, J = 6.3 Hz), 55.3, 29.2 (d, J = 5.1 Hz), 26.7 (d, J = 73.6 
Hz); IR (neat) v 2914, 1589, 1507, 1477, 1273, 1241, 1200, 1148, 1017, 816, 803, 783, 750, 740 cm-1; HRMS (ESI) 
calcd for C19H17NaO2P 331.0864 [M+Na]
+, found 331.0876. 
 
(racemic)-1-(3-Bromophenyl)-2,3-dihydro-1H-benzo[g]phosphindole-1-oxide (26). This was prepared according to 
General Procedure B using a solution of PO(3-BrPh)Cl2 (136.9 mg, 0.50 mmol) in THF (3.21 mL) and a solution of di-
Grignard reagent 15 (0.28 M in THF, 1.79 mL, 0.50 mmol). Flash chromatography (100% EtOAc to 2% NEt3/EtOAc) 
gave 26 (88.3 mg, 49%) as a white solid. mp 114−116 °C; TLC (2% NEt3/EtOAc) RF = 0.45; 
1H NMR (500 MHz, 
CDCl3) δ 8.09 – 8.03 (m, 1H), 7.99 (d, J = 8.5 Hz, 1H), 7.89 – 7.80 (m, 2H), 7.57 (d, J = 8.1 Hz, 1H), 7.52 – 7.40 (m, 
4H), 7.27 – 7.21 (m, 1H), 3.58 – 3.46 (m, 1H), 3.39 – 3.26 (m, 1H), 2.65 – 2.42 (m, 2H); 13C NMR (125 MHz, CDCl3) 
δ 148.2 (d, J = 31.7 Hz), 136.7 (d, J = 93.4 Hz), 134.7 (d, J = 2.6 Hz), 134.2 (d, J = 2.6 Hz), 133.0 (d, J = 11.1 Hz), 
132.7 (d, J = 7.8 Hz), 131.7 (d, J = 9.0 Hz), 130.2 (d, J = 12.6 Hz), 128.7 (d, J = 10.2 Hz), 128.4 (d, J = 1.4 Hz), 128.0, 
127.5 (d, J = 102.6 Hz), 126.4, 125.1 (d, J = 4.7 Hz), 123.9 (d, J = 12.9 Hz), 123.2 (d, J = 15.2 Hz), 28.7 (d, J = 4.8 
Hz), 27.9 (d, J = 71.8 Hz); IR (neat) v 2975, 2350, 1559, 1507, 1395, 1185, 1123, 1066, 824, 777, 681, 664 cm-1; 
HRMS (ESI) calcd for C18H14(
79Br)NaOP 378.9863 [M+Na]+, found 378.9868. 
 
(racemic)-1-(1-Naphthyl)-2,3-dihydro-1H-benzo[g]phosphindole-1-oxide (27). This was prepared according to General 
Procedure B using a solution of PO(1-naphthyl)Cl2 (122.5 mg, 0.50 mmol) in THF (3.33 mL) and a solution of di-
Grignard reagent 15 (0.30 M in THF, 1.67 mL, 0.50 mmol). Flash chromatography (100% EtOAc to 1% NEt3/EtOAc) 
gave 27 (129.8 mg, 79%) as a white solid. mp 208−210 °C; TLC (2% NEt3/EtOAc) RF = 0.77; 
1H NMR (300 MHz, 
CDCl3) δ 8.68 (d, J = 8.3 Hz, 1H), 8.31 (d, J = 7.5 Hz, 1H), 7.99 (d, J = 8.5 Hz, 1H), 7.95 – 7.80 (m, 3H), 7.60 – 7.30 
(m, 6H), 7.24 (t, J = 7.7 Hz, 1H), 3.55 – 3.35 (m, 1H), 3.22 – 3.04 (m, 1H), 2.74 – 2.55 (m, 2H); 13C NMR (75 MHz, 
CDCl3) δ 147.9 (d, J = 31.1 Hz), 133.8 (d, J = 2.5 Hz), 133.7 (d, J = 8.7 Hz), 132.8 (d, J = 9.1 Hz), 132.6 (d, J = 2.7 
Hz), 132.5, 132.4, 131.5 (d, J = 11.2 Hz), 129.5 (d, J = 93.7 Hz), 128.9, 128.4 (d, J = 1.5 Hz), 127.83, 127.82 (d, J = 
103.5 Hz), 127.3, 126.3, 126.2, 125.9 (d, J = 5.4 Hz), 125.6 (d, J = 4.6 Hz), 124.4 (d, J = 13.8 Hz), 124.1 (d, J = 12.7 
 
Hz), 28.7 (d, J = 4.9 Hz), 28.4 (d, J = 70.6 Hz); IR (neat) v 2990, 1507, 1199, 1187, 1160, 1058, 872, 836, 801, 775, 
732, 702, 672 cm-1; HRMS (ESI) calcd for C22H17NaOP 351.0915 [M+Na]
+, found 351.0904. 
 
(racemic)-1-tert-Butyl-2,3-dihydro-1H-benzo[g]phosphindole-1-oxide (28). This was prepared according to General 
Procedure B using a solution of PO(t-Bu)Cl2 (87.5 mg, 0.50 mmol) in THF (3.21 mL) and a solution of di-Grignard 
reagent 15 (0.28 M in THF, 1.79 mL, 0.50 mmol). Flash chromatography (2% NEt3/EtOAc) gave 28 (74.7 mg, 58%) as 
an off-white solid. mp 138−140 °C; TLC (2% NEt3/EtOAc) RF = 0.44; 
1H NMR (300 MHz, CDCl3) δ 8.52 (d, J = 8.2 
Hz, 1H), 7.93 (d, J = 8.4 Hz, 1H), 7.85 (d, J = 7.8 Hz, 1H), 7.61 – 7.45 (m, 2H), 7.33 (dd, J = 8.4, 2.3 Hz, 1H), 3.40 – 
3.20 (m, 1H), 3.16 – 3.01 (m, 1H), 2.62 – 2.48 (m, 1H), 2.36 – 2.14 (m, 1H), 1.20 (d, J = 15.0 Hz, 9H); 13C NMR (75 
MHz, CDCl3) δ 147.4 (d, J = 28.3 Hz), 133.4 (d, J = 2.8 Hz), 133.2 (d, J = 8.6 Hz), 132.7 (d, J = 7.6 Hz), 128.2, 127.3, 
126.6 (d, J = 2.9 Hz), 126.1, 125.3, 123.9 (d, J = 11.7 Hz), 34.9 (d, J = 67.9 Hz), 29.2 (d, J = 4.5 Hz), 24.7 (d, J = 1.4 
Hz), 23.4 (d, J = 62.7 Hz); IR (neat) v 2954, 1511, 1464, 1179, 1148, 873, 832, 815, 779, 735, 667, 640 cm-1; HRMS 
(ESI) calcd for C16H19NaOP 281.1071 [M+Na]
+, found 281.1077. 
 
(racemic)-1-Cyclohexyl-2,3-dihydro-1H-benzo[g]phosphindole-1-oxide (29). This was prepared according to General 
Procedure B using a solution of POCyCl2 (77.6 mg, 0.39 mmol) in THF (2.61 mL) and a solution of di-Grignard 
reagent 15 (0.31 M in THF, 1.25 mL, 0.39 mmol). Flash chromatography (100% EtOAc to 2% NEt3/EtOAc) gave 29 
(78.9 mg, 72%) as an off-white solid. mp 133−134 °C; TLC (2% NEt3/EtOAc) RF = 0.15; 
1H NMR (500 MHz, CDCl3) 
δ 8.44 (d, J = 8.2 Hz, 1H), 7.91 (d, J = 8.4 Hz, 1H), 7.86 (d, J = 8.2 Hz, 1H), 7.58 (t, J = 7.6 Hz, 1H), 7.50 (t, J = 7.6 
Hz, 1H), 7.32 (d, J = 8.5 Hz, 1H), 3.32 (td, J = 17.0, 10.0 Hz, 1H), 3.15 – 3.02 (m, 1H), 2.55 – 2.44 (m, 1H), 2.29 – 
2.08 (m, 3H), 1.87 – 1.76 (m, 1H), 1.76 – 1.58 (m, 3H), 1.45 – 1.31 (m, 1H), 1.31 – 1.10 (m, 4H); 13C NMR (125 MHz, 
CDCl3) δ 146.7 (d, J = 28.6 Hz), 133.1 (d, J = 2.8 Hz), 132.7 (d, J = 8.7 Hz), 132.4 (d, J = 7.7 Hz), 128.3 (d, J = 1.0 
Hz), 127.5, 127.0 (d, J = 93.5 Hz), 126.1, 125.5 (d, J = 3.6 Hz), 123.9 (d, J = 11.9 Hz), 39.9 (d, J = 68.0 Hz), 28.5 (d, J 
= 4.6 Hz), 26.1 (d, J = 5.5 Hz), 26.0 (d, J = 6.2 Hz), 25.8 (d, J = 1.6 Hz), 25.6 (d, J = 1.7 Hz), 25.4 (d, J = 2.8 Hz), 23.1 
(d, J = 65.0 Hz); IR (neat) v 2923, 2845, 1507, 1198, 1175, 828, 809, 779, 740 cm-1; HRMS (ESI) calcd for C18H22OP 
285.1408 [M+H]+, found 285.1404. 
 
(racemic)-1-Allyl-2,3-dihydro-1H-benzo[g]phosphindole-1-oxide (30). This was prepared according to General 
Procedure B using a solution of PO(allyl)Cl2 (79.5 mg, 0.50 mmol) in THF (4.95 mL) and a solution of di-Grignard 
reagent 15 (0.29 M in THF, 1.72 mL, 0.50 mmol). Flash chromatography (100% EtOAc to 5% NEt3/EtOAc) gave 30 
(75.3 mg, 62%) as a pale yellow gum. TLC (2% NEt3/EtOAc) RF = 0.10; 
1H NMR (500 MHz, CDCl3) δ 8.44 (d, J = 
8.3 Hz, 1H), 7.94 (d, J = 8.4 Hz, 1H), 7.89 (d, J = 8.2 Hz, 1H), 7.61 (t, J = 7.6 Hz, 1H), 7.53 (t, J = 7.8 Hz, 1H), 7.33 
(dd, J = 8.5, 2.3 Hz, 1H), 5.60 – 5.50 (m, 1H), 5.12 – 5.03 (m, 2H), 3.36 (td, J = 16.7, 10.0 Hz, 1H), 3.15 – 2.96 (m, 
3H), 2.53 – 2.45 (m, 1H), 2.36 – 2.23 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 146.5 (d, J = 30.3 Hz), 133.3, 132.4 (d, 
J = 7.7 Hz), 132.1 (d, J = 9.1 Hz), 128.4, 127.7, 127.6 (d, J = 104.6 Hz), 127.3 (d, J = 7.9 Hz), 126.2, 124.9 (d, J = 4.1 
Hz), 123.8 (d, J = 12.4 Hz), 119.9 (d, J = 11.8 Hz), 37.0 (d, J = 62.4 Hz), 28.4 (d, J = 4.6 Hz), 24.2 (d, J = 68.9 Hz); IR 
 
(neat) v 3410, 2927, 1510, 1204, 1176, 1150, 1116, 1010, 924, 818, 749 cm-1; HRMS (ESI) calcd for C15H15NaOP 
265.0758 [M+Na]+, found 265.0759. 
 
(racemic)-1-Dimethylamino-2,3-dihydro-1H-benzo[g]phosphindole-1-oxide (31). This was prepared according to 
General Procedure B using a solution of PO(NMe2)Cl2 (81.0 mg, 0.50 mmol) in THF (3.33 mL) and a solution of di-
Grignard reagent 15 (0.30 M in THF, 1.67 mL, 0.50 mmol). In this case, due to the potential susceptibility of the NMe2 
group to hydrolysis, the reaction was quenched by the addition of crushed ice (5 g) instead of water. Otherwise, work-
up was performed as described. Flash chromatography (2% NEt3/EtOAc) gave 31 (107.9 mg, 88%) as an off-white 
solid. mp 123−125 °C; TLC (2% NEt3/EtOAc) RF = 0.17; 
1H NMR (500 MHz, CDCl3) δ 8.28 (d, J = 8.3 Hz, 1H), 7.89 
(d, J = 8.5 Hz, 1H), 7.84 (d, J = 8.3 Hz, 1H), 7.56 (t, J = 7.7 Hz, 1H), 7.48 (t, J = 7.7 Hz, 1H), 7.29 (d, J = 7.8 Hz, 1H), 
3.32 – 3.20 (m, 1H), 3.20 – 3.08 (m, 1H), 2.61 (d, J = 10.4 Hz, 6H), 2.26 – 2.12 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 
147.4 (d, J = 35.3 Hz), 133.1 (d, J = 2.8 Hz), 132.3 (d, J = 7.6 Hz), 131.5 (d, J = 8.4 Hz), 128.1 (d, J = 1.2 Hz), 127.4, 
126.4 (d, J = 117.9 Hz), 126.0, 124.9 (d, J = 4.5 Hz), 124.1 (d, J = 13.8 Hz), 35.2 (d, J = 4.1 Hz), 26.9 (d, J = 6.8 Hz), 
22.1 (d, J = 85.8 Hz); IR (neat) v 2910, 1507, 1455, 1282, 1199, 974, 824, 752, 601, 647 cm-1; HRMS (ESI) calcd for 
C14H16NNaOP 268.0867 [M+Na]
+, found 268.0862. 
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